This HTML5 document contains 78 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbpedia-shhttp://sh.dbpedia.org/resource/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n7https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n18http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
dbpedia-srhttp://sr.dbpedia.org/resource/
freebasehttp://rdf.freebase.com/ns/
n12http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
dbpedia-vihttp://vi.dbpedia.org/resource/
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:CP-615,003
rdf:type
yago:Drug103247620 yago:Tranquilizer104470232 yago:Matter100020827 yago:DrugOfAbuse103248958 yago:Agent114778436 yago:WikicatAnxiolytics dbo:Drug yago:Medicine103740161 yago:PhysicalEntity100001930 n18:ChemicalObject yago:PsychotropicAgent104017429 yago:Sedative104166553 dbo:ChemicalSubstance yago:Sedative-hypnotic104166841 owl:Thing yago:CausalAgent100007347 yago:Substance100020090 yago:MinorTranquilizer103771443 wikidata:Q8386
rdfs:label
CP-615,003
rdfs:comment
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABAA receptors, and was developed by Pfizer as a potential anxiolytic; however, poor blood–brain barrier penetration make it primarily useful as a research ligand.
foaf:depiction
n12:CP-615003_structure.png
dcterms:subject
dbc:Anxiolytics dbc:Peripherally_selective_drugs dbc:GABAA_receptor_positive_allosteric_modulators dbc:Pfizer_brands
dbo:wikiPageID
31280551
dbo:wikiPageRevisionID
1094472759
dbo:wikiPageWikiLink
dbc:Pfizer_brands dbc:Peripherally_selective_drugs dbc:Anxiolytics dbr:Partial_agonist dbr:Anxiolytic dbr:Blood–brain_barrier dbc:GABAA_receptor_positive_allosteric_modulators dbr:GABA_A_receptor dbr:Pfizer
owl:sameAs
n7:4eeV7 dbpedia-sh:CP-615,003 yago-res:CP-615,003 dbpedia-vi:CP-615,003 freebase:m.0gjdrmj wikidata:Q5013579 dbpedia-sr:CP-615,003
dbp:wikiPageUsesTemplate
dbt:Anxiolytic-stub dbt:Reflist dbt:Cascite dbt:GABAAR_PAMs dbt:Drugbox dbt:Short_description dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite dbt:Drugbankcite
dbo:thumbnail
n12:CP-615003_structure.png?width=300
dbp:c
20
dbp:casNumber
329016
dbp:chemspiderid
7996623
dbp:f
1
dbp:h
24
dbp:iupacName
N--4-oxo-4,5,6,7-tetrahydro-1H-indole-3-carboxamide
dbp:n
3
dbp:o
3
dbp:pubchem
9820874
dbp:smiles
O=CC2=CNC3=C2C=O
dbp:stdinchi
1
dbp:stdinchikey
YZHJISPIBWKWGY-UHFFFAOYSA-N
dbp:unii
F8CYO0R7I1
dbp:verifiedfields
ohkar kyaw
dbp:verifiedrevid
artis
dbo:abstract
CP-615,003 is a drug which acts as a subtype-selective partial agonist at GABAA receptors, and was developed by Pfizer as a potential anxiolytic; however, poor blood–brain barrier penetration make it primarily useful as a research ligand.
gold:hypernym
dbr:Drug
prov:wasDerivedFrom
wikipedia-en:CP-615,003?oldid=1094472759&ns=0
dbo:wikiPageLength
3134
dbo:casNumber
329016-45-7
dbo:fdaUniiCode
F8CYO0R7I1
dbo:pubchem
9820874
foaf:isPrimaryTopicOf
wikipedia-en:CP-615,003